AS/NZS ISO 9001:2000

Click here to view share price


bioMD Limited ABN: 35 088 221 078
Copyright Disclaimer Privacy Policy
Corporate Governance

   

bioMD confirms the 14th patient implant of its CardioCel bioimplant.

For more information on the Phase II Clinical Trial click here


bioMD invites your comments and/or suggestions towards the progress of the Company and its service to you.
Please click here: info@biomd.com.au
Submit your email address to receive email broadcasts from bioMD
Subscribe Unsubscribe